DUBLIN–(BUSINESS WIRE)–The “Autologous Cell Therapy – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s providing.
Global Autologous Cell Therapy Market to Reach $29.3 Billion by 2027
Amid the COVID-19 disaster, the worldwide marketplace for Autologous Cell Therapy estimated at US$8.9 Billion within the yr 2020, is projected to succeed in a revised dimension of US$29.3 Billion by 2027, rising at a CAGR of 18.6% over the evaluation interval 2020-2027.
Bone Marrow, one of many segments analyzed within the report, is projected to document a 18.3% CAGR and attain US$17.1 Billion by the top of the evaluation interval. After an early evaluation of the enterprise implications of the pandemic and its induced financial disaster, development within the Epidermis phase is readjusted to a revised 20.2% CAGR for the following 7-year interval.
The U.S. Market is Estimated at $2.6 Billion, While China is Forecast to Grow at 18.3% CAGR
The Autologous Cell Therapy market within the U.S. is estimated at US$2.6 Billion within the yr 2020. China, the world’s second largest financial system, is forecast to succeed in a projected market dimension of US$5.2 Billion by the yr 2027 trailing a CAGR of 18.3% over the evaluation interval 2020 to 2027. Among the opposite noteworthy geographic markets are Japan and Canada, every forecast to develop at 16.6% and 15.8% respectively over the 2020-2027 interval. Within Europe, Germany is forecast to develop at roughly 13% CAGR.
Other Sources Segment to Record 17.2% CAGR
In the worldwide Other Sources phase, USA, Canada, Japan, China and Europe will drive the 17.2% CAGR estimated for this phase. These regional markets accounting for a mixed market dimension of US$1.1 Billion within the yr 2020 will attain a projected dimension of US$3.3 Billion by the shut of the evaluation interval.
China will stay among the many quickest rising on this cluster of regional markets. Led by international locations akin to Australia, India, and South Korea, the market in Asia-Pacific is forecast to succeed in US$3.4 Billion by the yr 2027.
Key Topics Covered:
II. EXECUTIVE SUMMARY
- Influencer Market Insights
- World Market Trajectories
- Impact of Covid-19 and a Looming Global Recession
III. MARKET ANALYSIS
(Total 42 Featured):
- BioTime, Inc.
- Brainstorm Cell Therapeutics, Inc.
- Caladrius Biosciences, Inc.
- Fibrocell Science, Inc.
- Opexa Therapeutics, Inc.
- Pharmicell Co., Ltd.
- Regeneus Ltd.
- TiGenix NV
- TxCell S.A.
- U.S. Stem Cell, Inc.
- Vericel Corporation
For extra details about this report go to https://www.researchandmarkets.com/r/57ibf3